Inside Innovation

Healionics, a medical technology company headquartered in Seattle, announced that its STARgraft arteriovenous (AV) graft for dialysis access has received Breakthrough Device designation from the

Derrick Hicks, Ph.D., a researcher in the Baker lab at the University of Washington’s Institute for Protein Design (IPD), has received a $387,050 grant by

Tune Therapeutics, a Seattle-based biotech company, is developing a groundbreaking approach to cure hepatitis B (HBV) by deactivating viral genes without damaging human DNA. The

Three Fred Hutch Cancer Center researchers have received over $4 million in grants from the Washington Research Foundation to advance immunotherapies for Merkel cell carcinoma,

AGC Biologics, led by new CEO Alberto Santagostino, plans to scale and strengthen its reputation as a customer-friendly, expert-driven CDMO. Building on AGC Biologics’ extensive

LumiThera, a Poulsbo-based medical device company specializing in ocular disease treatments, has received FDA clearance for the first-ever light-based therapy for dry age-related macular degeneration

The University of Washington infused $20.9 billion into Washington state’s economy last year, with UW Medicine accounting for $12.5 billion through its support of 60,700

Archon Biosciences, a Seattle-based spinout from the lab of Nobel Prize winner David Baker, has emerged from stealth mode with $20 million in funding for

Seattle-based startup Potato announced a $1 million pre-seed round surrounding their AI scientific research assistant, Potato AI. “The goal is really to enable researchers to

AGC Biologics, headquartered in Seattle, has announced the appointment of Alberto Santagostino to Chief Executive Officer and President. Santagostino has an extensive background in biotech,

A new wearable camera system developed by the University of Washington employs artificial intelligence to serve as an extra set of eyes in clinical settings,